CN Stock MarketDetailed Quotes

002399 Shenzhen Hepalink Pharmaceutical Group

Watchlist
  • 10.38
  • +0.10+0.97%
Not Open Jan 6 15:00 CST
15.23BMarket Cap-103.80P/E (TTM)

Shenzhen Hepalink Pharmaceutical Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Preparation1.45B51.23%
肝素钠以及低分子肝素钠原料药747.77M26.35%
CDMO560.38M19.75%
Other75.74M2.67%
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
Pharmaceutical manufacturing industry2.84B99.95%
Other industries1.29M0.05%
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
Abroad2.63B92.59%
Domestic210.24M7.41%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Top CN Stock Gainers
Symbol Price % Chg
XINGANJIANG
873167
19.16 +29.99%
Sichuan Goldstone
300434
9.46 +20.05%
Hangzhou Huasu Technology
301157
48.78 +20.00%
Suzhou Harmontronics Automation Technology
688022
12.30 +20.00%
Xinjiang Tianshan Animal Husbandry Bio-engineering
300313
6.43 +19.96%

See the daily top gainer.

Investment Theme Biomedical
Biomedical
Intraday+1.48%
Biological Vaccine
Biological Vaccine
Intraday+1.30%
Innovative Drugs
Innovative Drugs
Intraday+1.06%